Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21
October 08, 2021 07:00 ET
|
Renalytix
LONDON and SALT LAKE CITY, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will release fourth quarter and full year fiscal 2021 financial...
Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals
October 07, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the expansion of its commercial strategy to address early-stage kidney disease...
Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model
September 14, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the...
Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference
September 03, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming...
Renalytix Appoints Daniel J. Levangie to its Board of Directors
August 30, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Company’s board of directors. Mr....
Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX™ Testing at Primary Care Level
August 26, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the publication of results from an external chronic kidney disease budget...
Renalytix Appoints Ann Berman to its Board of Directors
July 28, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, July 28, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Ann E. Berman to its board of directors. She will chair the...
Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference
July 26, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 41st Annual...
Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory
July 22, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, July 22, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Joseph Hutson as its Vice President of Quality and...
KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time
June 28, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and...